Skip to main content
Supplement ScienceSupplementScience

Benefits of Omega-3

Evidence:Strong
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Cardiovascular protection — the REDUCE-IT trial (n=8,179) found 4g/day of icosapent ethyl (pure EPA) reduced major cardiovascular events by 25% compared to placebo
  • Anti-inflammatory effects — EPA and DHA are precursors to resolvins and protectins, which actively resolve inflammation; a 2017 meta-analysis found omega-3 supplementation reduced CRP levels significantly
  • Brain health and cognition — DHA comprises 40% of polyunsaturated fatty acids in the brain; higher omega-3 intake is associated with 26% reduced risk of dementia in observational studies
  • Depression and mood — a 2019 meta-analysis of 26 RCTs (n=2,160) found EPA-predominant formulas significantly reduced depression symptoms, with an effect size of 0.50
  • Joint health — 2,000-3,000mg EPA+DHA daily reduced morning stiffness and joint pain in rheumatoid arthritis patients comparable to NSAIDs in a 2017 systematic review

What the Research Says

Omega-3 fatty acids have demonstrated significant benefits across various health domains, supported by robust evidence from multiple studies. In cardiovascular health, the REDUCE-IT trial (Bhatt et al., 2019) highlighted that a high dose of pure EPA (4g/day) reduced major adverse cardiovascular events by 25%. More recently, Yan et al. (2024) conducted a systematic review and meta-analysis of 15 RCTs, confirming moderate evidence for the reduction of myocardial infarction and cardiovascular death with omega-3 supplementation, though noting an increased risk of atrial fibrillation.

For neurological health, Calderon Martinez et al. (2024) analyzed 14 studies involving 2766 participants, finding that omega-3 fatty acids, including EPA, DHA, and Souvenaid®, slowed cognitive decline in Alzheimer's disease patients as measured by the Clinical Dementia Rating scale. Additionally, a meta-analysis by Liao et al. (2019) confirmed that EPA-predominant formulas significantly alleviate depressive symptoms.

In terms of muscle health, Uchida et al. (2024) reviewed four studies and found that omega-3 supplementation combined with resistance training enhances muscle strength, though not mass. Furthermore, Pradelli et al. (2023) demonstrated that fish oil-based lipid emulsions outperform other intravenous lipid emulsions in improving clinical outcomes, highlighting the broader therapeutic potential of omega-3 fatty acids.

Overall, these findings underscore the diverse and significant benefits of omega-3 fatty acids across cardiovascular, neurological, and musculoskeletal health.

Related Conditions

Blood PressureBrain FogJoint PainImmune FunctionHeart HealthEye HealthCognitive FunctionHigh CholesterolAcneBack PainChronic PainDepressionEczemaFertilityFocusGoutHair LossIbdInflammationMuscle RecoveryOsteoarthritisPcosRespiratory HealthRheumatoid ArthritisStress
Ready to try Omega-3?
See our independently tested and ranked picks
Full Omega-3 Guide

References

  1. RCTBhatt DL, Steg PG, Miller M, et al. (2019). Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. New England Journal of Medicine. DOI PubMed
  2. Meta-analysisLiao Y, Xie B, Zhang H, et al. (2019). Efficacy of omega-3 PUFAs in depression: A meta-analysis. Translational Psychiatry. DOI PubMed
  3. Calder PC (2017). Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochemical Society Transactions. DOI PubMed
  4. Dyall SC (2015). Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Frontiers in Aging Neuroscience. DOI PubMed
  5. Meta-analysisYan J, Liu M, Yang D, Zhang Y, et al. (2024). Efficacy and Safety of Omega-3 Fatty Acids in the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis.. Cardiovascular drugs and therapy. DOI PubMed
  6. Uchida Y, Tsuji K, Ochi E (2024). Effects of Omega-3 fatty acids supplementation and resistance training on skeletal muscle.. Clinical nutrition ESPEN. DOI PubMed
  7. Meta-analysisCalderon Martinez E, Zachariah Saji S, Salazar Ore JV, Borges-Sosa OA, et al. (2024). The effects of omega-3, DHA, EPA, Souvenaid® in Alzheimer's disease: A systematic review and meta-analysis.. Neuropsychopharmacology reports. DOI PubMed
Show 4 more references
  1. Wang T, Zhang X, Zhou N, Shen Y, et al. (2023). Association Between Omega-3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose-Response Meta-Analysis of Randomized Controlled Trials.. Journal of the American Heart Association. DOI PubMed
  2. Wei BZ, Li L, Dong CW, Tan CC, et al. (2023). The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers.. The American journal of clinical nutrition. DOI PubMed
  3. Kelaiditis CF, Gibson EL, Dyall SC (2023). Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials.. Prostaglandins, leukotrienes, and essential fatty acids. DOI PubMed
  4. Meta-analysisDeng W, Yi Z, Yin E, Lu R, et al. (2023). Effect of omega-3 polyunsaturated fatty acids supplementation for patients with osteoarthritis: a meta-analysis.. Journal of orthopaedic surgery and research. DOI PubMed